Characterization of the Physicochemical, Spectral, Thermal and Behavioral Properties of Sodium Selenate: An Effect of the Energy of Consciousness Healing Treatment

Sodium selenate is a source of an essential nutrient selenium used for the prevention and treatment of cancer, heart diseases, viral diseases, diabetes, infectious diseases, etc. The aim of the study was to investigate the impact of Energy of Consciousness Healing Treatment (The Trivedi Effect®) on the physico-chemical, thermal, and behavioral properties of sodium selenate using PXRD, PSD, FT-IR, UV-vis, TGA, and DSC analysis. Sodium selenate was divided into two parts – one part was control/untreated sample, while another part was treated with Energy of Consciousness Healing Treatment remotely by twenty renowned Biofield Energy Healers and defined as the treated sample. The PXRD diffractograms showed sharp and intense peaks in both the samples, indicated both the samples were crystalline in nature. The crystallite size of the treated sample was significantly altered in the range of -16.66% to 50.07% compared with the control sample. Consequently, the average crystallite size of the treated sample was significantly increased by 9.57% compared to the control sample. The particle size of the treated sample at d10, d50, and d90 values were significantly increased by 9.47%, 19.06%, and 27.81%, respectively compared with the control sample. Thus, the surface area of the treated sample was significantly decreased by 9.16% compared to the control sample. The control and treated FT-IR spectra indicated the presence of sharp and strong absorption bands at 888 cm-1 due to the Se=O stretching. The wavelength of the maximum absorbance of the control and Biofield Energy Treated sodium selenate were at 206.3 nm and 205.9 nm, respectively in UV-vis spectroscopy. TGA analysis indicated that the total weight loss of the treated sample was reduced by 0.71% compared to the control sample. The DSC analysis showed that the vaporization temperature of the treated sample (94.97°C) was slightly decreased compared to the control sample (95.30°C). But, the latent heat of vaporization was significantly increased in the treated sample by 45.31% compared to the control sample. Thus, The Trivedi Effect® might lead to generate a new polymorphic form of sodium selenate, which would have better powder flowability and long-term storage stability compared with the control sample. The Biofield Energy Treated sodium selenate would be very useful to design better nutraceutical and pharmaceutical formulations which might offer a better therapeutic response against cancer, inflammatory diseases, infectious diseases, immunological disorders, stress, aging, Alzheimer’s disease, heart diseases, viral diseases, diabetes, infectious diseases, etc.

The experimental results revealed that Energy of Consciousness Healing Treatment (The Trivedi Effect®) displayed the significant impact on the physico-chemical, thermal, and behavioral properties of sodium selenate. The PXRD analysis showed the remarkable alteration of the crystallite size of the treated sample from -16.66% to 50.07% compared with the control sample. Overall, the average crystallite size of the Biofield Energy Treated sodium selenate was significantly increased by 9.57% compared with the control sample. This result indicated that the crystal morphology of the treated sodium selenate was changed from the control sample and The Trivedi Effect® - Biofield Energy Healing Treatment might lead to a new polymorphic form of sodium selenate. The particle size of the Biofield Energy Treated sample at d10, d50, and d90 values were significantly increased by 9.47%, 19.06%, and 27.81%, respectively compared with the control sample. Therefore, the surface area of the treated sample was significantly decreased by 9.16% compared with the control sample. TGA analysis revealed that the total weight loss of the Biofield Energy Treated sample was reduced by 0.71% compared with the control sample. The DSC analysis revealed that the vaporization temperature of the treated sample (94.97°C) was decreased slightly compared to the control sample (95.30°C). The latent heat of vaporization was increased significantly in the Biofield Energy Treated sample by 45.31% compared to the control sample. The TGA and DSC analysis revealed that the Biofield Energy Treated sample might have improved thermal stability compared with the control sample. Briefly, the Biofield Energy Treated sodium selenate might be a new polymorphic form of sodium selenate having increased crystallite/particle size, and decreased surface area. Thus, The Trivedi Effect® - Biofield Energy Treated sodium selenate could be better powder flowability and long-term storage stability compared with the control sample. Hence, The Trivedi Effect® treated sodium selenate would be useful to design better nutraceutical and pharmaceutical formulations that might offer better therapeutic response against various diseases such as diabetes mellitus, allergies, septic shock, insomnia, anxiety, depression, Attention Deficit Disorder, Attention Deficit Hyperactive Disorder, mental restlessness, brain frog, low libido, impotency, lack of motivation, mood swings, confusion, migraines, headaches, forgetfulness, overwhelm, worthlessness, loneliness, indecisiveness, frustration, irritability, chronic fatigue, Lupus, Systemic Lupus Erythematosus, Hashimoto Thyroiditis, Asthma, Chronic peptic ulcers, Tuberculosis, Hepatitis, Chronic active hepatitis, Celiac Disease, Addison Disease, Crohn's disease, Graves’ Disease, Pernicious and Aplastic Anemia, Sjogren Syndrome, Irritable Bowel Syndrome, Arthritis, osteoporosis, Chronic periodontitis, Multiple Sclerosis, Ulcerative colitis, Chronic sinusitis, Myasthenia Gravis, Atherosclerosis, Vasculitis, Dermatitis, Diverticulitis, Alopecia Areata, Psoriasis, Scleroderma, Fibromyalgia, Chronic Fatigue Syndrome and Vitiligo, cardiovascular disease, cancer, Alzheimer's disease, dementia, cataracts, hypertension, glaucoma, hearing loss, Parkinson's Disease, Huntington's Disease, Prion Disease, Motor Neuron Disease, Spinocerebellar Ataxia, Spinal muscular atrophy, Friedreich's Ataxia, Amyotrophic lateral sclerosis, Lewy Body Disease, chronic infections and much more.